Guide to OCD Symptoms Types and Treatment Options

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Obsessive compulsive disorder, often shortened to OCD, is a long lasting mental health condition marked by unwanted intrusive thoughts, repetitive behaviors, repetitive mental acts, or both, and those symptoms can take up significant time, cause distress and interfere with daily life.

If you live with OCD, the condition can affect far more than a few visible habits. It can shape how long it takes you to leave the house, how much doubt you feel after simple decisions, how safe you feel in your own mind and how much energy daily tasks demand. Many people know their rituals are excessive, yet still feel driven to repeat them because the short drop in anxiety after a compulsion can feel urgent and hard to resist.

You may picture OCD as handwashing, checking or arranging, but the disorder also includes quiet forms that other people may never see. Some people repeat prayers silently, review memories for hours, ask for reassurance again and again, avoid ordinary situations, or scan their own body and thoughts for signs of danger. These patterns can look different on the surface while following the same internal cycle.

This guide explains how that cycle works, which subtypes are most common, what treatment usually involves and what options may come up when standard care has not helped enough.

Recognizing the cycle of obsessions and compulsions

OCD usually runs on a repeating loop. An intrusive thought, image, urge or sensation shows up. You feel alarm, disgust, guilt, dread or uncertainty. You respond with a compulsion meant to reduce that tension. Relief arrives for a short time. Then the doubt returns, often stronger than before, and the cycle starts again. That loop is one of the key reasons OCD can become so sticky over time.

Obsessions are unwanted and recurring. They may involve contamination, harm, sex, religion, morality, health, relationships, symmetry or fear of losing control. A thought can feel deeply upsetting because it clashes with your values. That clash is common in OCD. A violent thought does not predict violent behavior. A blasphemous thought does not tell you what you believe. A sexual intrusive image does not tell you what you want. In OCD, the problem is often the meaning you attach to the thought and the emergency response that follows.

Compulsions are the actions or mental rituals used to lower distress or prevent a feared outcome. They can be physical, such as washing, checking, arranging, touching, repeating or avoiding. They can also be mental, such as counting, reviewing, neutralizing, praying, replacing a bad thought with a good one, or asking yourself for one final bit of certainty. Mental compulsions still count as compulsions. They keep the loop going in the same way visible rituals do.

A major feature of OCD is the urge for certainty. You may want to know with total confidence that the stove is off, that you did not offend someone, that your partner is right for you, that your prayer was pure enough, or that a passing thought does not reveal something terrible. The drive for perfect certainty can take over your day because real life rarely offers absolute proof. OCD exploits that gap and turns ordinary doubt into a crisis.

The relief after a compulsion is real, but it is brief. Your brain learns that the ritual seemed to prevent danger or calm fear, so it tags the ritual as important and asks for it again next time. That pattern is one reason clinicians focus so much on response prevention. When you reduce the ritual, the brain gets a chance to learn that the feared outcome does not need to be controlled in that way.

OCD can also pull you into avoidance. You might avoid knives, public restrooms, mirrors, sharp turns while driving, church, reading, dating, pregnancy news, or any topic that triggers doubt. Avoidance can feel safer in the short term, but it usually shrinks your life and keeps fear untested. Over time, the list of triggers can expand.

Many people with OCD know the fear is exaggerated. That insight does not switch the symptoms off. You can know a thought is irrational and still feel driven to perform a ritual. This is part of why the condition is so exhausting. You may be fighting on two fronts at once, against the fear itself and against shame about having the fear at all.

The disorder can also show up in childhood and adolescence. Symptoms often begin between late childhood and young adulthood, though onset can vary. In younger people, adults may notice the pattern before the child can explain it clearly. Stress can make symptoms worse, and symptom content may shift over time even when the core cycle stays the same.

Signs that the pattern may be OCD

A repeated thought alone does not always mean OCD. Repetitive behavior alone does not always mean OCD either. The condition becomes more likely when the pattern includes several of the following points.

  • You feel driven to do a ritual, ask for reassurance, avoid a trigger or repeat a mental act to calm fear
  • The pattern takes up a lot of time, often more than an hour a day
  • Relief fades quickly and the urge returns
  • The symptoms interfere with work, school, sleep, relationships or basic daily tasks
  • You feel stuck chasing certainty, safety, correctness or moral clarity that never feels complete

These features line up with standard clinical descriptions of OCD and help separate the disorder from ordinary caution, routine or preference. (

How OCD can affect daily life

OCD can slow nearly every part of your routine. Mornings may start with checking locks, appliances, texts, clothing or bodily sensations. Work can become hard if you reread messages for hidden mistakes, repeat tasks until they feel just right, or get trapped in mental review after meetings. Home life can tighten around cleaning, ordering, contamination fears or relationship doubt. Sleep can suffer because obsessions often intensify in quiet moments.

The social cost can be heavy too. You may hide symptoms because you fear being judged or misunderstood. Loved ones may get drawn into accommodation, such as answering the same question many times, helping with rituals or changing routines to reduce your distress. That can bring temporary peace, but it often strengthens OCD over time.

OCD also overlaps with other conditions. Mood disorders, anxiety disorders and tic disorders are common alongside OCD. That overlap can make diagnosis harder and can blur the picture if the person seeking help talks only about anxiety, guilt, sleeplessness or depression without naming the obsessions and compulsions directly.

The most common subtypes you need to know

OCD is one diagnosis, but the themes can differ a lot from person to person. These subtypes are not separate official diagnoses in every case, yet they are useful ways to describe the main fear pattern and ritual pattern you may be dealing with.

Contamination OCD

Contamination OCD centers on fears about germs, dirt, chemicals, bodily fluids, illness or feeling polluted in a moral or emotional sense. You may wash, shower, sanitize, change clothes, throw items away or avoid places and people that feel contaminated. The fear often goes past ordinary hygiene and can lead to skin damage, long routines and major interference with daily life.

This subtype can also include fear of spreading contamination to other people. That can create guilt and strong avoidance. A doorknob, shopping cart, package, bathroom, shoe sole or even a thought can become loaded with perceived danger. The distress is real even when the threat estimate is badly inflated.

Harm OCD

Harm OCD involves intrusive fears about causing harm to yourself or others. You may get violent images, fear you could lose control, or replay past moments to check that no harm happened. Common rituals include avoiding knives, staying away from driving, checking the news for accidents, asking loved ones if they are safe, or mentally reviewing your intentions. These intrusive thoughts are usually ego dystonic, meaning they feel unwanted and out of step with your values.

People with harm OCD often feel intense shame because the content is so upsetting. That shame can delay care. The symptom itself is the problem. The presence of the thought does not mean you want it or plan to act on it.

Relationship OCD

Relationship OCD focuses on doubt about your partner, your feelings, your partner’s feelings, or the rightness of the relationship. You may scan for flaws, compare your relationship to other people’s, confess every passing doubt, search for certainty that you are in love enough, or ask for repeated reassurance. The cycle can damage closeness because it turns attention inward and makes ordinary relationship ambiguity feel unbearable.

This subtype can also target dating decisions, marriage, attraction and long term compatibility. The issue is less about a single relationship problem and more about the way OCD converts doubt into a constant alarm state.

Pure O

The phrase Pure O is often used for presentations dominated by intrusive thoughts and hidden mental rituals. The compulsions are still there. They are just easier to miss because they happen inside the mind. You may review memories, test your feelings, repeat phrases, argue with the thought, search for mental proof, or try to cancel one thought with another.

This form can be hard to spot because there may be little outward behavior for other people to notice. The person can look calm from the outside while spending hours trapped in internal rituals.

Religious OCD

Religious OCD, often called scrupulosity, involves obsessive fear around sin, moral failure, blasphemy, impurity or offending a higher power. Compulsions may include repeated prayer, confession, mental review, rereading, reassurance seeking from religious leaders, or avoiding sacred spaces and practices that trigger fear. The person may care deeply about faith and still feel tormented by thoughts that feel alien and offensive.

Symmetry and just right OCD

Some people feel driven by a need for exactness, symmetry or a just right sensation. Objects may need to be arranged, aligned, tapped or repeated until the feeling lands correctly. The distress may center less on a specific disaster and more on internal tension, discomfort or a sense of incompleteness. Even so, the cycle still follows the same pattern of obsession, compulsion and short relief.

Somatic or sensorimotor OCD

Somatic OCD involves fixation on body processes such as breathing, blinking, swallowing, heartbeat or eye contact. Once attention locks on, you may feel unable to stop monitoring the sensation. That can produce panic, self consciousness and more monitoring, which fuels the loop. The problem is not the body process itself. The problem is the obsessive attention and the rituals used to control or test it.

Sexual orientation, sexual intrusive thoughts and taboo themes

OCD can also center on sexual thoughts, orientation fears, incest fears, pedophilia themed obsessions, or other taboo material that feels horrifying to the person having it. These themes often carry intense shame and secrecy. Many people delay treatment because they fear the content will be taken literally. In OCD, intrusive content often targets what you care about most or what you fear most.

Hoarding symptoms and related patterns

Hoarding disorder is now treated as its own diagnosis in standard diagnostic systems, but some people with OCD still have saving rituals, checking, contamination fears tied to discarding, or intrusive guilt about losing something important. If the main engine is obsession and compulsion, OCD may still be part of the picture. A careful clinical assessment helps sort that out.

Common threads across subtypes

The theme may change, but the core mechanics stay similar. You feel a spike of alarm. You try to neutralize it. Relief shows up for a short time. Then the need for certainty returns. That is why treatment often targets the process more than the content. If you spend all your energy debating the topic of the obsession, OCD usually finds a new topic later. If you change your response to the obsession, the loop can weaken.

Standard therapies and daily management techniques

OCD is treatable. Standard care usually includes psychotherapy, medication, or both. Many people improve with these methods, including people with severe symptoms. Treatment often takes time and usually works best when it is specific to OCD rather than general anxiety support alone.

Exposure and response prevention

Exposure and response prevention, often shortened to ERP, is one of the main evidence based treatments for OCD. In ERP, you gradually face a trigger in a planned way and then resist the ritual that usually follows. The aim is to let anxiety rise and fall without using the compulsion. Over repeated practice, the brain can learn that the feared result does not need to be controlled through ritual and that distress can pass on its own.

ERP is hard work. It asks you to do the exact thing OCD says to avoid. You may touch something that feels contaminated and delay washing. You may write down a feared phrase and sit with the discomfort. You may leave the house without checking one more time. You may stop asking for reassurance after an intrusive thought. The early phase can feel rough, and drop out is a real issue for some people. Still, ERP has strong support and can reduce compulsions even in people who did not respond well to medication.

Good ERP is gradual and planned. You do not start with the hardest trigger on day one. A therapist often helps build a ladder of feared situations, from easier items to harder ones, then guides practice in a way that is steady enough to be repeatable. The main task is not to prove your fear false through argument. The task is to change your behavior in the presence of uncertainty.

Cognitive behavioral therapy

Cognitive behavioral therapy is also widely used in OCD care. In this setting, CBT may include learning how intrusive thoughts work, identifying mental rituals, spotting inflated threat estimates and reducing unhelpful responses. For many people, ERP sits inside a broader CBT plan. The exact form can vary, but the most effective therapy is usually built around OCD specific methods rather than generic stress advice.

Medication

Medication can be an important part of treatment. Serotonin reuptake medications, especially selective serotonin reuptake inhibitors, are commonly used for OCD. They often take longer to work for OCD than many people expect, sometimes around 8 to 12 weeks before symptom improvement appears, and the doses used for OCD can be higher than those commonly used for depression. Medication side effects can happen, so treatment usually involves monitoring and dose adjustment with a clinician.

Some people do best with ERP alone. Some do best with medication alone. Many do best with both together. The combination can be useful when symptoms are severe enough that therapy feels hard to engage in without some decrease in baseline distress.

Family work and reducing accommodation

If your family, partner or close friends get pulled into rituals, treatment may also include reducing accommodation. That can mean less answering of repeated reassurance questions, less helping with checking and less adjustment of shared routines around OCD rules. This change often feels uncomfortable at first because symptoms may spike before they improve. Still, reducing accommodation can be a major part of long term progress.

Daily management techniques

Daily management does not replace formal treatment, but it can support it. The methods below can help reduce fuel going into the OCD loop.

Label the process quickly

When an obsession hits, it helps to identify what is happening in simple terms. You can say to yourself that this is an intrusive thought, a reassurance urge, a checking urge, or a contamination fear. The point is to name the pattern without debating the content for ten minutes.

Delay the ritual

A short delay can weaken the automatic link between fear and compulsion. You might postpone checking for ten minutes, then twenty, then longer. Even small delays count because they create space for a different response.

Limit reassurance

Reassurance feels calming for a moment, but it often functions like a compulsion. If you ask the same question in slightly different ways, search the same topic again and again, or repeat the event in your head to get certainty, the cycle usually tightens.

Track time spent on rituals

A written record can show where the day is going. Many people underestimate how much time mental rituals and avoidance consume. A simple log can reveal patterns and help you see where to start.

Protect sleep and routine

OCD often intensifies when you are exhausted or under high stress. Regular sleep, meals and daily rhythm will not cure the disorder, but they can reduce the raw strain on your system and make therapy work more manageable.

Stop arguing with every thought

Trying to prove an obsession wrong in real time can become a ritual. In many cases, the better move is to allow the thought to exist without answering it fully. That feels incomplete, which is exactly why it can help.

What diagnosis and assessment may involve

Assessment usually includes a clinical interview focused on the content of obsessions, the type of compulsions, how much time symptoms consume, how much avoidance is present and how daily life is affected. Because OCD can be hidden, honest detail matters. If you tell a clinician only that you feel anxious, depressed or guilty, they may miss the obsessive pattern. A clear description of the rituals, including mental rituals, helps direct you toward the right care.

When traditional medicine fails to provide relief

Some people improve a lot with ERP, medication or both. Some improve partly. Some remain highly impaired even after trying standard care in a serious way. Treatment resistant OCD usually refers to symptoms that stay severe after adequate trials of first line treatment. Estimates vary by study, but published reviews note that a substantial minority of patients do not improve enough with conventional therapy. One review cited about 25 to 30 percent of patients as failing to improve after treatment, while a recent trial listing noted that up to 40 percent may not respond to conventional care.

There are several reasons this can happen. The diagnosis may be incomplete. Hidden mental rituals may still be driving the loop. Symptoms may be so intense that ERP is hard to continue. Depression, tics, trauma related symptoms or substance use may complicate treatment. Some brains may also respond differently to serotonin based medication or show a more rigid symptom pattern linked to underlying circuitry. Research reviews point to roles for fronto striatal circuits along with serotonergic and glutamatergic systems in OCD biology.

Medication changes and augmentation

When first line medication does not help enough, a prescribing clinician may adjust the dose, change the medication, extend the trial or consider augmentation. The exact path depends on side effects, symptom severity, coexisting conditions and what has already been tried. These decisions need close clinical oversight because higher doses and combination plans can increase risk and side effects.

Neuromodulation

For severe cases that do not respond to standard care, neuromodulation can enter the conversation. Federal material notes that deep repetitive transcranial magnetic stimulation was approved in 2018 as an adjunct treatment for severe OCD that had not responded to other treatments, and that approval was later extended to standard TMS devices in 2022. This treatment uses magnetic pulses aimed at specific brain areas linked to OCD symptoms.

In a smaller subset of very severe cases, deep brain stimulation has also been studied and used in specialist settings. Published review material describes DBS as an option for some people with highly refractory illness, though it is much more invasive and reserved for select cases.

Why research now focuses on circuits and plasticity

OCD is increasingly studied through the lens of brain circuits, habit formation, inhibitory control and plasticity. Reviews describe the cortico striato thalamo cortical circuit as a major model for OCD pathophysiology, with serotonin and glutamate systems also playing important roles. This does not reduce the disorder to one single cause, but it gives researchers a map for studying why some people stay trapped in repetitive threat loops and why some treatments help more than others.

The idea of plasticity is especially relevant because OCD can feel hard wired. Repeated rituals can strengthen learned responses, but treatment can also support new patterns. ERP is one example. Repeated practice without ritual can help build a different response to fear. Some research programs are now asking if circuit based treatments or carefully studied compounds might make that learning process more accessible for people with severe or refractory symptoms.

Psychedelic research and OCD

Psychedelic therapy for OCD is still a research area, not a routine standard treatment. Registered clinical studies have examined or are examining psilocybin in people with OCD, including studies focused on feasibility, safety, repeated dosing, treatment resistant OCD and the role of cognitive inflexibility and neural plasticity. That means the field is active, but it also means the work is still being tested in formal research settings rather than established as ordinary care.

This area draws attention because OCD often involves rigid repetitive patterns and because early research questions are centered on flexibility, symptom relief and how guided treatment may interact with entrenched fear loops. At the same time, careful limits matter. A registered study is not proof that the treatment is ready for broad clinical use. The field still needs controlled data, longer follow up and careful screening standards.

When to seek help quickly

You should seek professional help if obsessions or compulsions are consuming hours of the day, causing major distress, affecting work or school, straining relationships, leading to self harm risk, or pushing you toward alcohol or drug use to cope. You should also seek help quickly if the content of the obsession makes you afraid to disclose it. Hidden symptoms often worsen in isolation, and OCD can become more severe over time when untreated.

Conclusion

As you look into future treatment paths, Rose Hill Life Sciences are a psychedelic research organization specializing in the production and research of Psilocybe cubensis, operating at the intersection of science and therapeutic integration, and based in Massachusetts.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.